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Epidemiological studies often rely on self-reported informa-
tion, as this renders the costs of data collection lower than that 
of clinical studies.1 However, the validity and reliability of 
the instruments used for data collection are often not reported.2
Commonly, the Cohen’s kappa coefficient is used to 
determine inter-rater agreement for disease (or other cat-
egorical outcomes) by comparing self-reported informa-
tion against a gold standard (diagnostic test, medical 
records, physiological measures, etc.). Previous valida-
tion studies of self-reported diabetes diagnosis have 
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indicated that diabetes is reported more accurately than 
other illnesses or diseases.3–10
The Cohen’s kappa coefficient can also be used to analyze 
the test–retest reliability of an instrument. Many studies 
from Norway have used self-reported information from 
questionnaires as the principle tool, but few11–43 of them have 
provided information on the reproducibility of the individual 
items and instruments therein. It is important to establish that 
respondents with different socio-demographic background, 
and age groups have understood the questions in a similar 
manner. Test–retest reliability is assessed by measuring the 
responses of the same study sample to an identical question 
at two or more points in time.44 These responses are then 
compared to establish the reliability of the instrument. The 
chi-square (χ2) test for independence is not appropriate for 
assessing test–retest reliability since it does not take into 
account that the data are paired (i.e. different measurements 
for the same individual).
Previous studies using self-reported data from interviews 
have studied the test–retest reliability of self-reported diabe-
tes diagnosis, with inconsistent kappa agreements.45–50 Since 
type 2 diabetes typically affects people aged 40 years and 
over,51,52 it is possible to differentiate between the test–retest 
reliability of self-reported type 1 and type 2 diabetes diagno-
ses using information on age at diagnosis. No previous study 
was found that assessed the test–retest reliability for either 
type 1 or type 2 diabetes separately.
The Norwegian Women and Cancer (NOWAC) Study53 
is a prospective cohort study in which women reported dia-
betes diagnosis and age at diagnosis in three separate ques-
tionnaires. If a woman accurately reported her diabetes 
diagnosis in one study, she is expected to report the same in 
a subsequent study. This assumption underlies our test–
retest reliability analysis. The aim of this study was to 
assess the test–retest reliability of self-reported diabetes 
diagnosis, as well as that of type 1 and type 2 diabetes diag-
noses separately. Furthermore, the large sample size per-
mits subgroup analyses and sensitivity analysis. We 
examined whether test–retest reliability varies with age, 
body mass index (BMI), physical activity, education, and 
smoking status.
Methods
Study cohort and sampling
The NOWAC Study is a prospective nationwide study 
which started in 1991,54,55 and contains data from 170,000 
women. Participants were randomly selected from the 
National Population Register of Norway. The external 
validity of the study56 and validity of some measures57–59 
have been published elsewhere. NOWAC Study partici-
pants are assumed to be representative of the female 
Norwegian population in the corresponding age groups.56 
The detailed characteristics of the participants are described 
elsewhere,56 and the updated information on the NOWAC 
Study is accessible on its website.54
Of the 170,000 women enrolled in the NOWAC Study, 
33,919 women completed all of three questionnaires sent in 
1991, 1998, and 2005. The general characteristics of the 
study sample and the association between BMI and type 2 
diabetes in this sample are described elsewhere.52
Questionnaire and classification
Diabetes. Information on diabetes diagnosis was collected 
by means of the same question in all three questionnaires 
(1991, 1998, and 2005): “Have you had any of the following 
diseases?” The list of options included diabetes. Age at diag-
nosis was measured with the subsequent question, “If yes, at 
what age was it first discovered?” For the purposes of this 
study, only participants who reported having diabetes and 
provided their age at diagnosis were defined as diabetes 
cases. If participants reported they gave birth to a child either 
the same year they were diagnosed with diabetes, or in the 
year preceding child birth, it was assumed that they had ges-
tational diabetes, and they were excluded from the analysis. 
Final numbers of diabetes cases included in analyses are 
given in Tables 2–4. Participants with missing values on dia-
betes diagnosis and age at diagnosis were excluded.
Using the responses to the questions on diabetes and age 
at diagnosis, different variables for diabetes diagnosis, and 
separate variables for type 1 and type 2 diabetes, were cre-
ated. Since type 2 diabetes typically affects people aged 
40 years or over,51,52 we classified only those aged 40 years 
or over as having type 2 diabetes. Women who were diag-
nosed with diabetes at or before age 39 years were catego-
rized as having type 1 diabetes (excluding those with 
gestational diabetes). Participants with type 1 and type 2 dia-
betes were classified separately by the above-mentioned cri-
teria for the 1991 test study, the 1998 test study, the 1998 
retest study for comparison against 1991 test study, the 2005 
retest study for comparison against the 1991 test study, and 
the 2005 retest study for comparison with the 1998 test study.
Diabetes cases in the 1991 and 1998 test studies were 
defined as those who reported having diabetes, and their age 
at diagnosis in the corresponding questionnaires. One 
respondent to the 1998 questionnaire fulfilled the criteria for 
both gestational diabetes and type 2 diabetes and was finally 
classified as having gestational diabetes only.
Diabetes in the 1998 retest study (for comparison against the 
1991 test study). Diabetes cases in the 1998 retest study, for 
comparison against the 1991 test study were defined as 
those with diabetes from the 1998 test study, provided they 
reported a date of diagnosis prior to 1992. The same criteria 
were applied to women with type 1 or type 2 diabetes. One 
women in the 1998 retest study fulfilled the criteria both for 
gestational and type 2 diabetes and was finally classified as 
having gestational diabetes only.
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Diabetes in the 2005 retest study (for comparison against the 
1991 test study). Diabetes cases from the 2005 retest study, 
for comparison against 1991 test study, were defined as par-
ticipants who reported a diabetes diagnosis in the 2005 ques-
tionnaire, provided they reported a date of diagnosis prior to 
1992. The same criteria were applied to women with type 1 
or type 2 diabetes.
Diabetes in the 2005 retest study (for comparison against 1998 
test study). Diabetes cases from the 2005 retest study, for 
comparison against the 1998 test study, were defined as par-
ticipants with self-reported diabetes in the 2005 question-
naire, provided that they reported a date of diagnosis prior to 
1999. The same criteria were applied to women with type 1 
or type 2 diabetes.
Covariates. Self-reported information on height and weight 
from 1998 study was used to calculate BMI (kg/m2). BMI 
was categorized into three groups: normal weight (BMI: 
<25 kg/m2), overweight (BMI: 25–29.9 kg/m2), and obese 
(BMI: ⩾30 kg/m2). Smoking status was derived from the 
replies to two questions in the 1998 questionnaire: “Have 
you ever smoked?” (yes, no) and “Do you smoke on a daily 
basis at the moment?” (yes, no). Women who answered “no” 
to the former were categorized as “never smokers.” Those 
who answered “yes” to the former, and “no” to the latter, 
were categorized as “former smokers,” and those who 
answered “yes” to both questions were categorized as “cur-
rent smokers.” A 10-category scale measured the level of 
self-reported physical activity in the 1998 questionnaire, the 
validity of which has been reported previously.21 Responses 
to questions about physical activity were used to assign a 
category of physical activity: low [1–3], medium [4–7], and 
high [8–10]. Education (duration in years) was categorized 
into four groups: primary/intermediate (0–9), secondary 
(10–12), university (13–16), and postgraduate and above 
(17+). Age (years) was categorized in four groups with 
5-year interval.
Statistical analysis
Statistical analysis was performed with SAS version 9.2 and 
Stata version 13.1. Means (standard deviation (SD)) were 
estimated for all continuous variables, and the percentage of 
participants in each category was calculated for all categori-
cal variables. General characteristics of the data are presented 
as frequencies, percentages, and means with SDs, respec-
tively (Table 1). Variables for all diabetes diagnoses, as well 
as for type 1 and type 2 diabetes separately, were constructed, 
and the kappa agreement for the two types of diabetes was 
calculated for the 1991–1998 test–retest study, the 1991–2005 
test–retest study, and 1998–2005 test–retest study, respec-
tively. The kappa coefficients summarize the total agreement 
beyond that expected by chance. 95% confidence intervals 
(CIs) for kappa statistic were estimated with analytical 
method60 in Stata.61 Established benchmarks62,63 for rating the 
strength of kappa agreements as poor (<0.20), fair (>0.20 to 
⩽0.40), moderate (>0.40 to ⩽0.60), good (>0.60 to ⩽0.80), 
and very good (>0.80 to ⩽1.00) were used.
Consistency (%) was calculated as
 
Consistency(%)
Number of diabetes diagnosis




diagnosis in test study
×100
Sensitivity analysis
Since self-reported age at diagnosis was used as the only dis-
criminative criterion for distinguishing between type 1 and 
type 2 diabetes, sensitivity analysis was performed by 
restricting age at diagnosis <35 years for type 1 diabetes and 
age at diagnosis >44 years for type 2 diabetes (Table 5). 
Those reporting age at diagnosis 35-44 were excluded for the 
purpose of assessing sensitivity of the kappa agreements 
(Table 5).
Subgroup analysis
Subgroup analysis was performed to assess the consistency 
of the kappa agreement across stratas of the covariates 
(Tables 6–10).
Ethical approval
The NOWAC Study was approved by the Regional 
Committee for Medical and Health Research Ethics. All par-
ticipating women gave written informed consent.
Results
Table 1 presents the general characteristics of the study sam-
ple. Among the 33,919 women participating in 1991, 1998, 
and 2005 study, the age distribution was between 40 and 59 
(mean: 47.7 ± 4.3) in 1998. Majority (64.6%) of the respond-
ents had normal weight (BMI: <25 kg/m2). Almost 40.3% of 
the respondents had some university education or more. 
Most (75.5%) of the respondents were classified as having 
medium level of physical activity. In this study sample, 
28.2% were classified as being current smoker, while 31.2% 
were classified as being former smokers.
Table 2 presents the self-reported diabetes diagnosis in 
1991 study, and 1998 study by self-reported age at diagnosis 
in respective studies. Majority (56%) of the self-reported 
diabetics reported age at diagnosis as 30 years or over in 
1991 study, while over 64.7% reported age at diagnosis as 
40 years or over in the 1998 study. This may partly be due to 
the aging cohort itself.
Tables 3 and 4 present the kappa statistics for the test–
retest studies. The agreement for all self-reported diabetes 
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diagnoses in the 1991–1998 test–retest study was 0.75 (95% 
CI: 0.70–0.81), while it was 0.70 (95% CI: 0.66–0.74) in the 
1998–2005 test–retest study. The kappa agreement for all 
self-reported diabetes diagnoses in the 1991–2005 test–retest 
study was 0.65 (95% CI: 0.58–0.71) (Table 3).
Table 4 shows the kappa agreement for the three test–
retest studies separately for the two types of diabetes. The 
kappa agreement for type 1 diabetes was very good in the 
1991–1998 test–retest study (kappa = 0.83, 95% CI: 0.76–
0.89), while it was good in the 1991–2005 test–retest study 
(kappa = 0.76, 95% CI: 0.68–0.84), and the 1998–2005 test–
retest study (kappa = 0.73, 95% CI: 0.66–0.81). The kappa 
agreement for type 2 diabetes was good in the 1991–1998 
test–retest study (kappa = 0.67, 95% CI: 0.55–0.79), and in 
the 1998–2005 test–retest study (kappa = 0.66, 95% CI: 
0.59–0.72), while it was moderate in the 1991–2005 test–
retest study (kappa = 0.57, 95% CI: 0.43–0.71) (Table 4). The 
overall kappa agreement in the 1991–1998 test–retest study 
was stronger than in the 1991–2005 test–retest study and the 
1998–2005 test–retest study (Table 4).
Table 5 presents the sensitivity of the kappa agreements 
by classifying those reporting age at diagnosis less than 35, 
as diagnosed with type 1 diabetes. While, classifying those 
reporting age at diagnosis greater than 44 as diagnosed with 
type 2 diabetes. The kappa agreements remained moderate to 
good for type 1 diabetes, while the kappa agreements for 
type 2 diabetes were fair to good (Table 5).
Tables 6–10 present the kappa agreement for diabetes 
stratified by age, BMI, physical activity, education, and 
smoking status. There was no clear pattern of inconsistency 
in the kappa agreements within different strata of age, BMI, 
physical activity, and smoking (Table 6–8 and 10). However, 
the stratified analysis by the level of education shows that 
the kappa agreement is strongest among the most educated 
group (Table 9) in all the test–retest comparisons, while gen-
erally it was weaker among the least educated group.
Discussion
In this study, we analyzed the test–retest reliability of self-
reported diabetes diagnosis in a large sample of middle-aged 
women in Norway. We observed that the agreement was 
good for all diabetes diagnoses combined in all three test–
retest studies. The weakest agreement was found in the 
1991–2005 test–retest study. This was to be expected, as the 
time interval between these studies was the longest. These 
results also suggest that other confounding factors may have 
affected self-reported diabetes diagnosis in the 1991–1998, 
or 1998–2005 test–retest studies, as the agreement in these 
periods was expected to be more similar. The fact that diabe-
tes diagnosis may change over time could have contributed 
to the decreasing agreement observed between the 1991–
1998 test–retest study and the 1991–2005 test–retest study. 
However, looking at the two types of diabetes separately 
revealed some differences in the kappa agreement. The 
Table 1. General characteristics of the study sample 
(n = 33,919).
Cohort n = 33,919
 N (%) Mean (SD)
Age (years) 47.7 (4.3)
 40–44 9926 (29.3)  
 45–49 11,382 (33.6)  
 50–54 10,849 (32.0)  
 55–59 1762 (5.2)  
BMIa 24.4 (3.8)
 Normal weight (<25 kg/m2) 21,553 (64.6)  
 Overweight (25–29.9 kg/m2) 9106 (27.3)  
 Obese (⩾30 kg/m2) 2709 (8.1)  
Education level (duration in  
years)a
12.5 (3.2)
 Primary/intermediate (0–9) 6736 (20.1)  
 Secondary (10–12) 12,102 (36.1)  
 University (13–16) 10,226 (30.5)  
 Postgraduate and above (17+) 4460 (13.3)  
Physical activity levela 5.6 (1.7)
 Low 3686 (11.5)  
 Medium 24,229 (75.5)  
 High 4186 (13.0)  
Smoking status  
 Never smoker 13,763 (40.6)  
 Former smoker 10,582 (31.2)  
 Current smoker 9574 (28.2)  
SD: standard deviation; BMI: body mass index.
a Cohort size was 33,919, but because of missing values, the numbers for 
some variables do not add up to 33,919.
Table 2. Self-reported diabetes diagnosis in 1991 and 1998 test 







 n (%) n (%)
Age at diagnosis 0–4 5 (3.4)c 4 (1.3)d
 5–9 10 (6.8)c 6 (1.9)d
 10–14 18 (12.2)c 17 (5.4)d
 15–19 10 (6.8)c 11 (3.5)d
 20–24 7 (4.7)c 12 (3.8)d
 25–29 15 (10.1)c 12 (3.8)d
 30–34 23 (15.5)c 19 (6.0)d
 35–39 23 (15.5)c 30 (9.5)d
 40–44 25 (16.9)c 75 (23.8)d
 45–49 12 (8.1)c 70 (22.2)d
 50–54 – 59 (18.7)d
 Total 148 (100.0) 315 (100.0)
a Diabetes cases in the 1991 test study were defined as those who reported 
having diabetes, and their age at diagnosis in the 1991 study.
b Diabetes cases in the 1998 test study were defined as those who 
reported having diabetes, and their age at diagnosis in the 1998 study. 
One respondent to the 1998 questionnaire fulfilled the criteria for both 
gestational diabetes and type 2 diabetes and was excluded.
cN and % of respondents reporting age at diagnosis in 1991 study.
dN and % of respondents reporting age at diagnosis in 1998 study.
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Table 3. Kappa agreements for self-reported diabetes diagnoses (excluding gestational diabetes).
Test study Retest study Consistency (%)a Kappa (95% CI)
Diabetes Cases in 1991 (n) Cases in 1998 (n)  
 148 151 113/148 (76.4) 0.75 (0.70–0.81)
 Cases in 1991 (n) Cases in 2005 (n)  
 148 130 90/148 (60.8) 0.65 (0.58–0.71)
 Cases in 1998 (n) Cases in 2005 (n)  
 315 282 209/315 (66.3) 0.70 (0.66–0.74)
CI: confidence interval.
a Consistency(%) = Number of diabetes diagnosis in both
 test and retest study 
Number of diabetesdiagnosis in test study
10× 0 .
Table 4. Kappa agreements for self-reported type 1 and type 2 diabetes diagnoses.
Diabetes type Test study Retest study Consistency (%)a Kappa (95% CI)
Cases in 1991 (n) Cases in 1998 (n)  
Type 1 diabetesb 111 103 83/111 (74.7) 0.83 (0.76–0.89)
Type 2 diabetesc 37 48 29/37 (78.4) 0.67 (0.55–0.79)
 Cases in 1991 (n) Cases in 2005 (n)  
Type 1 diabetesb 111 88 64/111 (57.6) 0.76 (0.68–0.84)
Type 2 diabetesc 37 42 21/37 (56.6) 0.57 (0.43–0.71)
 Cases in 1998 (n) Cases in 2005 (n)  
Type 1 diabetesb 111 97 70/111 (63.1) 0.73 (0.66–0.81)
Type 2 diabetesc 204 185 125/204 (61.3) 0.66 (0.59–0.72)
CI: confidence interval.
aConsistency(%) =
Number of diabetesdiagnosisinboth test andretest study
Number of diabetesdiagnosisin test study
100× .
bType 1 diabetes were classified as those reporting age at diagnosis <40 years.
cType 2 diabetes were classified as those reporting age at diagnosis >39 years.
Table 5. Sensitivity analysis of kappa agreements for self-reported type 1 (age at diagnosis: <35 years) and type 2 diabetes diagnoses 
(age at diagnosis: >44 years).
Diabetes type Test study Retest study Consistency (%)a Kappa (95% CI)
Cases in 1991 (n) Cases in 1998 (n)  
Type 1 diabetesb 88 81 68/88 (77.3) 0.80 (0.65–0.95)
Type 2 diabetesc 12 15 6/12 (50.0) 0.52 (0.27–0.77)
 Cases in 1991 (n) Cases in 2005 (n)  
Type 1 diabetesb 88 74 54/88 (61.4) 0.69 (0.51–0.88)
Type 2 diabetesc 12 12 3/12 (25.0) 0.33 (0.05–0.61)
 Cases in 1998 (n) Cases in 2005 (n)  
Type 1 diabetesb 81 74 57/81 (70.4) 0.60 (0.38–0.81)
Type 2 diabetesc 129 123 75/129 (58.1) 0.63 (0.56–0.70)
CI: confidence interval.
aConsistency(%) =
Number of diabetes diagnosis in both test and retest study
Number of diabetesdiagnosisin test study
100× .
bOnly those reporting age at diagnosis <35 years were included.
cOnly those reporting age at diagnosis >44 years were included.
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kappa agreement for type 1 diabetes was weakest in the 
1998–2005 test–retest study, which was very close to the 
kappa agreement for the ~14-year interval in the 1991–2005 
test–retest study. In summary, the results show that although 
the agreement for all self-reported diabetes was weakest in 
the 1991–2005 test–retest study, this was not the case when 
analyzing the kappa agreement for the two types of diabetes 
separately. This suggests that recall problems may not be an 
important determinant of the accuracy of self-reported dia-
betes diagnosis.
One possible reason for the higher kappa agreement 
among women with type 1 diabetes in our study is that these 
women may have severe complications sooner64 than women 
with type 2 diabetes; this may have contributed the women’s 
recall of age at diagnosis, resulting in a higher agreement for 
type 1 diabetes.
Table 6. Kappa agreements for self-reported diabetes diagnoses (excluding gestational diabetes) stratified by age groups.
Test study Retest study Consistency (%)a Kappa (95% CI)
Cases in 1991 (n) Cases in 1998 (n)  
Age 40–44 38 31 27/38 (71.1) 0.78 (0.67–0.89)
 45–49 39 38 27/39 (69.2) 0.70 (0.58–0.82)
 50–54 59 65 48/59 (81.4) 0.77 (0.69–0.86)
 55–59 12 17 11/12 (91.7) 0.76 (0.58–0.93)
 Cases in 1991 (n) Cases in 2005 (n)  
Age 40–44 38 30 26/38 (68.4) 0.76 (0.65–0.88)
 45–49 39 35 24/39 (61.5) 0.65 (0.52–0.77)
 50–54 59 54 34/59 (57.6) 0.60 (0.49–0.71)
 55–59 12 11 6/12 (50.0) 0.52 (0.27–0.77)
 Cases in 1998 (n) Cases in 2005 (n)  
Age 40–44 64 57 42/64 (65.6) 0.69 (0.60–0.79)
 45–49 75 66 49/75 (65.3) 0.69 (0.61–0.78)
 50–54 143 131 98/143 (68.5) 0.71 (0.65–0.77)
 55–59 33 28 20/33 (60.6) 0.65 (0.51–0.79)
CI: confidence interval.
aConsistency(%)=
Number of diabetes diagnosis in both test and retest study
Number of diabetesdiagnosis in test study
100× .
Table 7. Kappa agreements for self-reported diabetes diagnoses (excluding gestational diabetes) stratified by BMI.
Test study Retest study Consistency (%)a Kappa (95% CI)
Cases in 1991 (n) Cases in 1998 (n)  
 Normal weight (<25 kg/m2) 62b 62 49/62 (79.0) 0.79 (0.71–0.87)
BMI Overweight (25–29.9 kg/m2) 44b 48 35/44 (79.5) 0.76 (0.66–0.86)
 Obese (⩾30 kg/m2) 41b 41 29/41 (70.7) 0.70 (0.59–0.82)
 Cases in 1991 (n) Cases in 2005 (n)  
 Normal weight (<25 kg/m2) 62b 59c 44/62 (80.0) 0.73 (0.64–0.82)
BMI Overweight (25–29.9 kg/m2) 44b 35c 21/44 (47.7) 0.53 (0.40–0.66)
 Obese (⩾30 kg/m2) 41b 35c 25/41 (61.0) 0.65 (0.53–0.78)
 Cases in 1998 (n) Cases in 2005 (n)  
 Normal weight (<25 kg/m2) 99d 89e 74/99 (74.7) 0.79 (0.72–0.85)
BMI Overweight (25–29.9 kg/m2) 99d 83e 59/99 (59.6) 0.65 (0.56–0.73)
 Obese (⩾30 kg/m2) 114d 106e 74/114 (64.9) 0.79 (0.72–0.85)
CI: confidence interval; BMI: body mass index.
a
Consistency(%) =
Number of diabetes diagnosis in both test andretest study
Number of diabetes diagnosis in test study
100× .
bThe numbers do not add up to 148 due to missing values on height or weight (consequently on BMI).
cThe numbers do not add up to 130 due to missing values on height or weight (consequently on BMI).
dThe numbers do not add up to 315 due to missing values on height or weight (consequently on BMI).
eThe numbers do not add up to 282 due to missing values on height or weight (consequently on BMI).
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Table 8. Kappa agreements for self-reported diabetes diagnoses (excluding gestational diabetes) stratified by physical activity.
Test study Retest study Consistency (%)a Kappa (95% CI)
Cases in 1991 (n) Cases in 1998 (n)  
 Low 24b 31c 19/24 (79.2) 0.68 (0.54–0.82)
Physical activity level Medium 106b 101c 80/106 (75.5) 0.77 (0.71–0.84)
 High 11b 11c 8/11 (72.7) 0.73 (0.52–0.94)
 Cases in 1991 (n) Cases in 2005 (n)  
 Low 24b 27d 18/24 (75.0) 0.74 (0.56–0.85)
Physical activity level Medium 106b 86d 63/106 (59.4) 0.66 (0.58–0.73)
 High 11b 9d 5/11 (45.5) 0.50 (0.23–0.77)
 Cases in 1998 (n) Cases in 2005 (n)  
 Low 62e 57f 43/62 (69.4) 0.72 (0.63–0.81)
Physical activity level Medium 209e 188f 139/209 (66.5) 0.70 (0.65–0.75)
 High 26e 25f 17/26 (65.4) 0.67 (0.52–0.82)
CI: confidence interval.
aConsistency(%) =
Number of diabetes diagnosis in both test and retest study
Number of diabetes diagnosis in test study
100× .
bThe numbers do not add up to 148 due to missing values on physical activity level.
cThe numbers do not add up to 151 due to missing values on physical activity level.
dThe numbers do not add up to 130 due to missing values on physical activity level.
eThe numbers do not add up to 315 due to missing values on physical activity level.
fThe numbers do not add up to 282 due to missing values on physical activity level.
Table 9. Kappa agreements for self-reported diabetes diagnoses (excluding gestational diabetes) stratified by education level.
Test study Retest study Consistency (%)a Kappa (95% CI)
Cases in 1991 (n) Cases in 1998 (n)  
 Primary/intermediate (0–9) 35b 40c 28/35 (80) 0.75 (0.64–0.86)
Education level 
(duration in years)
Secondary (10–12) 63b 70c 50/63 (79.4) 0.75 (0.67–0.83)
 University (13–16) 33b 24c 21/33 (63.6) 0.74 (0.61–0.87)
 Postgraduate and above (17+) 14b 15c 13/14 (92.9) 0.90 (0.78–1.00)
 Cases in 1991 (n) Cases in 2005 (n)  
 Primary/intermediate (0–9) 35b 32d 18/35 (51.4) 0.54 (0.39–0.68)
Education level 
(duration in years)
Secondary (10–12) 63b 53d 37/63 (58.7) 0.64 (0.53–0.74)
 University (13–16) 33b 30d 24/33 (72.7) 0.76 (0.64–0.88)
 Postgraduate and above (17+) 14b 12d 10/14 (71.4) 0.77 (0.59–0.95)
 Cases in 1998 (n) Cases in 2005 (n)  
 Primary/intermediate (0–9) 85e 78f 55/85 (64.7) 0.67 (0.59–0.75)
Education level 
(duration in years)
Secondary (10–12) 133e 112f 85/133 (64.0) 0.69 (0.62–0.76)
 University (13–16) 63e 61f 45/63 (71.4) 0.72 (0.64–0.81)




Number of diabetes diagnosis in both test and retest study
Number of diabetes diagnosis in test study
100× .
bThe numbers do not add up to 148 due to missing values on education level.
cThe numbers do not add up to 151 due to missing values on education level.
dThe numbers do not add up to 130 due to missing values on education level.
eThe numbers do not add up to 315 due to missing values on education level.
fThe numbers do not add up to 282 due to missing values on education level.
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Since type 2 diabetes typically affects people 40 years of 
age and over,51,52 we classified only women aged 40 years 
and over as having type 2 diabetes. However, it is still pos-
sible that women younger than 40 years of age have devel-
oped type 2 diabetes.65–69 In addition, cases identified as 
having gestational diabetes were excluded from the type 2 
diabetes group, although women who had gestational diabe-
tes may develop type 2 diabetes later in life.70,71 Women aged 
39 years or less who reported a diabetes diagnosis (excluding 
gestational diabetes) were categorized as having type 1 dia-
betes. Since type 1 diabetes can occur at any age,72 it is also 
possible that some of the women classified as having type 2 
diabetes in fact had type 1 diabetes. Due to the design and 
self-reported nature of the study, it was not possible to con-
firm the exact type(s) of diabetes diagnosis. The results from 
sensitivity analysis restricting type 1 diabetes cases to those 
reporting age at diagnosis less than 35 years, and restricting 
type 2 diabetes to those reporting age at diagnosis more than 
44 years, were still acceptable.
This study was larger than previous studies, permitting 
subgroup analyses. No clear pattern of inconsistency in 
kappa agreements was observed between different strata of 
BMI, physical activity, and smoking status. Although no for-
mal test of heterogeneity was performed to assess the statisti-
cal difference in kappa agreements across the subgroups, 
there was a pattern across education groups. The kappa 
agreement was strongest among the most educated group, 
while generally it was weaker among the least educated 
group.
Although the NOWAC cohort is representative of 
Norwegian women in corresponding age groups, the current 
sample may not be a representative sample since it includes 
only the women participating in all the three waves of the 
study. Furthermore, the respondents with missing values 
were excluded. Some research suggests that those belonging 
to the low socio-economic strata, and are relatively unhealthy, 
are likely to have a higher proportion of missing values in 
observational study.73 Multiple imputation (MI) was not per-
formed, since the kappa statistic61 is not supported with MI 
software’s74–77 in Stata. Therefore, the possibility of selec-
tion bias limits the external validity of this study.
The kappa agreement we report here is not comparable to 
other studies63,78 due to differences in the proportion of peo-
ple reporting a certain type of diabetes in different studies, or 
differences in distribution. We found few studies assessing 
the test–retest reliability of diabetes diagnosis, and the results 
of those that were found were not consistent. Most showed 
very good agreement45–49,79 between the test and the retest 
studies, while others showed a good50 or moderate80 level of 
agreement. However, most of the studies we found46–49,80 did 
not report either the significance probability or the CIs. One 
possible reason for the higher kappa agreement reported in 
previous studies45–50 may be the relatively small time inter-
val between the test and retest studies, as compared to the 
~7- or ~14-year interval in our study. The relatively smaller 
time interval between the test and retest studies may have 
caused respondents in other populations to remember their 
previous response more easily, resulting in a higher kappa 
coefficient.
Another key difference between previous studies45–50 and 
our study was their use of interview to collect the informa-
tion on diabetes diagnosis. As these studies used an inter-
view setting, it is reasonable to assume that the respondent 
had a chance to ask for questions to be repeated, or for fur-
ther explanation/clarification, and that the interviewer might 
have provided it. This may have helped the respondents to 
understand the question better, and to therefore report more 
accurately. It is probable that this key difference in 
Table 10. Kappa agreements for self-reported diabetes diagnoses (excluding gestational diabetes) stratified by smoking status.
Test study Retest study Consistency (%)a Kappa (95% CI)
Cases in 1991 (n) Cases in 1998 (n)  
 Never smoker 51 47 38/51 (74.5) 0.78 (0.68–0.87)
Smoking status Former smoker 51 50 37/51 (72.5) 0.73 (0.63–0.83)
 Current smoker 46 54 38/46 (82.6) 0.76 (0.67–0.85)
 Cases in 1991 (n) Cases in 2005 (n)  
 Never smoker 51 41 29/51 (56.9) 0.63 (0.51–0.75)
Smoking status Former smoker 51 40 31/51 (60.8) 0.68 (0.57–0.79)
 Current smoker 46 49 30/46 (65.2) 0.63 (0.52–0.74)
 Cases in 1998 (n) Cases in 2005 (n)  
 Never smoker 108 94 72/108 (66.7) 0.71 (0.64–0.78)
Smoking status Former smoker 103 93 62/103 (60.2) 0.63 (0.55–0.71)
 Current smoker 104 95 75/104 (72.1) 0.75 (0.68–0.82)
CI: confidence interval.
aConsistency(%) =
Number of diabetes diagnosis in both test and retest study
Number of diabetes diagnosis in test study
100× .
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the investigation tool increases the kappa agreement for the 
test–retest reliability of the studies using interviews to col-
lect data.
However, a study from Manhattan (New York)80 reported 
on the test–retest reliability of diabetes diagnosis using tele-
phone interviews. The retest study was conducted within 
30 days of the test study, and the kappa agreement between 
the test and retest studies was found to be 0.48, which is very 
low considering the short time interval, and despite the use 
of interviews to collect data. This shows that a short time 
interval between the test and the retest study and the use of 
interviews do not necessarily increase the kappa agreement.
The strength of this study is that, it is the first to assess the 
test–retest reliability of self-reported diabetes diagnosis sep-
arately for type 1 and type 2 diabetes. Other strengths of our 
study include a large cohort size, sensitivity of the estimates 
by self-reported age at diagnosis, and subgroup analysis 
within different covariates. This study provides new insights 
into earlier research by providing the reliability of self-
reported diagnosis separately for type 1 and type 2 diabetes.
Strengths and limitation of this study
•• Large (n = 33,919) longitudinal population-based 
study.
•• First to assess the test–retest reliability of self-reported 
diabetes diagnosis separately for type 1 and type 2 
diabetes.
•• Some women younger than 40 years of age may have 
developed type 2 diabetes.
•• Women with gestational diabetes were excluded, 
although they may develop type 2 diabetes later in 
life.
Conclusion
In conclusion, this study shows that the reliability of the 
self-reported information on diabetes diagnosis from a 
large prospective cohort study with long time interval is 
satisfactory.
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